Innovative 'Bottlebrush' Nanoparticles Target Tumors with Precision, Minimizing Chemotherapy Side Effects
Scientists at MIT have developed 'bottlebrush' nanoparticles that can deliver large doses of chemotherapy drugs directly to cancer cells, potentially reducing treatment side effects. These specialized particles are engineered with antibodies that guide them precisely to tumor sites, heralding a new era in targeted cancer therapies.